07:48 AM EDT, 05/30/2025 (MT Newswires) -- TriSalus Life Sciences ( TLSI ) said Friday that it has appointed David B. Patience as chief financial officer, starting July 1.

Patience succeeds James Young, who stepped down for personal reasons, effective immediately, but remains available to assist with the transition, according to the company.

Patience most recently served as CFO of Accelerate Diagnostics, the company said.

TriSalus said Vice President of Finance Dan Giordano will serve as acting CFO during the transition period.